3 Stocks Driving The Health Services Industry Higher

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 57 points (0.3%) at 16,611 as of Monday, Aug. 11, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 2,452 issues advancing vs. 535 declining with 124 unchanged.

The Health Services industry currently sits up 0.8% versus the S&P 500, which is up 0.6%. Top gainers within the industry include Mindray Medical International ( MR), up 2.6%, Smith & Nephew ( SNN), up 2.1%, Community Health Systems ( CYH), up 2.0%, Covidien ( COV), up 1.2% and Express Scripts ( ESRX), up 0.6%. A company within the industry that fell today was Bruker ( BRKR), up 2.4%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3. Baxter International ( BAX) is one of the companies pushing the Health Services industry higher today. As of noon trading, Baxter International is up $0.74 (1.0%) to $74.64 on light volume. Thus far, 780,934 shares of Baxter International exchanged hands as compared to its average daily volume of 2.3 million shares. The stock has ranged in price between $74.13-$74.97 after having opened the day at $74.18 as compared to the previous trading day's close of $73.90.

Baxter International Inc. develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney diseases, trauma, and other chronic and acute medical conditions. Baxter International has a market cap of $40.0 billion and is part of the health care sector. Shares are up 6.1% year-to-date as of the close of trading on Friday. Currently there are 4 analysts who rate Baxter International a buy, no analysts rate it a sell, and 10 rate it a hold.

TheStreet Ratings rates Baxter International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins, increase in stock price during the past year and notable return on equity. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Baxter International Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Abbott Laboratories ( ABT) is up $0.37 (0.9%) to $42.06 on light volume. Thus far, 1.1 million shares of Abbott Laboratories exchanged hands as compared to its average daily volume of 5.4 million shares. The stock has ranged in price between $41.63-$42.16 after having opened the day at $41.92 as compared to the previous trading day's close of $41.69.

Abbott Laboratories manufactures and sells health care products worldwide. Abbott Laboratories has a market cap of $62.4 billion and is part of the health care sector. Shares are up 8.3% year-to-date as of the close of trading on Friday. Currently there are 10 analysts who rate Abbott Laboratories a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Abbott Laboratories as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. However, as a counter to these strengths, we find that net income has been generally deteriorating over time. Get the full Abbott Laboratories Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Intuitive Surgical ( ISRG) is up $2.58 (0.6%) to $446.61 on light volume. Thus far, 151,565 shares of Intuitive Surgical exchanged hands as compared to its average daily volume of 511,700 shares. The stock has ranged in price between $438.50-$450.95 after having opened the day at $442.87 as compared to the previous trading day's close of $444.03.

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Intuitive Surgical has a market cap of $15.9 billion and is part of the health care sector. Shares are up 15.0% year-to-date as of the close of trading on Friday. Currently there are 10 analysts who rate Intuitive Surgical a buy, 2 analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Intuitive Surgical as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, expanding profit margins, solid stock price performance and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Intuitive Surgical Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Oil Prices, China Tariffs, Micron and Kohl's - 5 Things You Must Know

Oil Prices, China Tariffs, Micron and Kohl's - 5 Things You Must Know

China Slashes Auto Import Tariffs as Trump's Trade Push Gets Big Early Win

China Slashes Auto Import Tariffs as Trump's Trade Push Gets Big Early Win

Global Stocks Push Higher as China Tariff Move, Softer US Dollar Boost Sentiment

Global Stocks Push Higher as China Tariff Move, Softer US Dollar Boost Sentiment

U.S. Crude Oil Hits Fresh 3-Year Highs as Gas Prices March to $3 a Gallon

U.S. Crude Oil Hits Fresh 3-Year Highs as Gas Prices March to $3 a Gallon

Video: When Planning for Retirement, Don't Underestimate Your Life Span

Video: When Planning for Retirement, Don't Underestimate Your Life Span